Abstract:BackgroundCommunity-acquired pneumonia is a leading infectious cause of hospitalization. A few vaccines exist to prevent pneumococcal disease in adults, including a pneumococcal polysaccharide unconjugated vaccine and a protein conjugated polysaccharide vaccine. Previous studies on the human immune response to the unconjugated vaccine showed that the vaccine boosted the existing memory B cells. In the present study, we investigated the human B cell immune response following pneumococcal polysaccharide conjugate vaccination.MethodsPlasmablast B cells from a pneumococcal polysaccharide conjugate vaccinee were isolated and cloned for analysis. In response to primary vaccination, identical sequences from the plasmablast-derived antibodies were identified from multiple B cells, demonstrating evidence of clonal expansion. We evaluated the binding specificity of these human monoclonal antibodies in immunoassays, and tested there in vitro function in a multiplexed opsonophagocytic assay (MOPA). To characterize the plasmablast B cell response to the pneumococcal conjugated vaccine, the germline usage and the variable region somatic hypermutations on these antibodies were analyzed. Furthermore, a serotype 4 polysaccharide-specific antibody was tested in an animal challenge study to explore the in vivo functional activity.ResultsThe data suggests that the pneumococcal polysaccharide conjugate vaccine boosted memory B cell responses, likely derived from previous pneumococcal exposure. The majority of the plasmablast-derived antibodies contained higher numbers of variable region somatic hypermutations and evidence for selection, as demonstrated by replacement to silent ratio's (R/S) greater than 2.9 in the complementarity-determining regions (CDRs). In addition, we found that VH3/JH4 was the predominant germline sequence used in these polysaccharide-specific B cells. All of the tested antibodies demonstrated narrow polysaccharide specificity in ELISA binding, and demonstrated functional opsonophagocytic killing (OPK) activity in the MOPA assay. The in-vivo animal challenge study showed that the tested serotype 4 polysaccharide-specific antibody demonstrated a potent protective effect when administered prior to bacterial challenge.ConclusionsThe findings on the pneumococcal polysaccharide conjugate vaccine responses from a vaccinated subject reported in this study are similar to previously published data on the pneumococcal polysaccharide unconjugated vaccine responses. In both vaccine regimens, the pre-existing human memory B cells were expanded after vaccination with preferential use of the germline VH3/JH4 genes.

Mild Acute Stress Prevents the Memory Impairment Induced by Long-Term Isoflurane Anesthesia

<i>Streptococcus pneumoniae</i> specific Th17 memory immunity provides cross protection against invasive pneumococcal diseases in mice. (IRC9P.701)

Protective Immunity Against Invasive Streptococcus Pneumoniae Infections by Tissue-Specific Memory Th17 Cells (P4266)

Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection

Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection

[Inhibitory Effect of Suramin on Inflammatory Response in Pulmonary Tissue and Peripheral Blood in LPS-induced Septic Mice].

[Heat Shock Response in Experimental Acute Middle Ear Bacterial Infection].

The role of 5-HT7R in the memory impairment of mice induced by long-term isoflurane anesthesia

Human monoclonal antibodies protect against viral-mediated pneumococcal superinfection

Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants.

Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection

Immunization with pneumococcal polysaccharide serotype 3 and lipopolysaccharide modulates lung and liver inflammation during a virulent Streptococcus pneumoniae infection in mice

Immunoinformatics Prediction and Protective Efficacy of Vaccine Candidate PiuA-PlyD4 Against Streptococcus Pneumoniae

Antibodies to Conserved Surface Polysaccharides Protect Mice Against Bacterial Conjunctivitis

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Effect of passive immunization with serotype-specific monoclonal antibodies on Actinobacillus pleuropneumoniae infection of mice

Protection From The Acquisition Of Staphylococcus Aureus Nasal Carriage By Cross-Reactive Antibody To A Pneumococcal Dehydrogenase

Human Monoclonal Antibodies Isolated from a Primary Pneumococcal Conjugate Vaccinee Demonstrates the Expansion of an Antigen-Driven Hypermutated Memory B Cell Response

Innate immune stimulation by monophosphoryl lipid A prevents chronic social defeat stress-induced anxiety-like behaviors in mice

Effects of overexpression of Hsp70 in neural stem cells on neurotoxicity and cognitive dysfunction in neonatal mice under sevoflurane exposure

Isoflurane-Induced Spatial Memory Impairment In Mice Is Prevented By The Acetylcholinesterase Inhibitor Donepezil